SWP
RMD icon

Stratos Wealth Partners’s ResMed RMD Stock Holding History

Stratos Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,716
Closed -$385K – 1765
2026
Q1 		$385K Buy
1,716
+361
+27% +$90K ﹤0.01% 1182
2025
Q4 		$327K Buy
1,355
+59
+5% +$15.1K ﹤0.01% 1240
2025
Q3 		$355K Buy
1,296
+69
+6% +$18.8K ﹤0.01% 1170
2025
Q2 		$317K Buy
+1,227
New +$293K ﹤0.01% 1118
2018
Q4 		– Sell
-167
Closed -$19K – 2144
2018
Q3 		$19K Buy
+167
New +$18.3K ﹤0.01% 1905
2018
Q2 		– Sell
-59
Closed -$6K – 2235
2018
Q1 		$6K Buy
59
+8
+16% +$756 ﹤0.01% 2555
2017
Q4 		$4K Buy
+51
New +$4.21K ﹤0.01% 2464

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stratos Wealth Partners's RMD Position: Q2 2026 in Review

Stratos Wealth Partners sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,716 shares — an estimated $385K sold.

Stratos Wealth Partners first reported a position in RMD in Q4 2017 and held it in 7 quarters. The position peaked at $385K in Q1 2026. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Stratos Wealth Partners reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,716 ResMed shares in Q2 2026, an estimated $385K.
  • Stratos Wealth Partners first reported a position in ResMed in Q4 2017 and held it in 7 quarters.
  • Stratos Wealth Partners's ResMed position peaked at $385K in Q1 2026.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.